Fasting insulin levels predict fatal cardiovascular (CVD) events more accurately than any other marker of glucose metabolism. The 10-year follow-up of the ATTICA study (2002–2012)

      Objectives: According to latest guidelines for CVD prevention, diabetic subjects should be treated with secondary prevention guidelines, even if their medical history is free of CVD. Taken into account that the diagnosis of diabetes is given using blood glucose levels, there is still information regarding the role of hyperinsulinemia that is missing. Thus, several glucose metabolism markers might be more useful in order to identify high CVD risk subjects.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect